Back to All

Diaceutics appoints Damian Thornton as Chief Operating Officer

28 November, 2018

Dundalk, 28 November 2018 – Diaceutics, the diagnostic commercialisation company helping to improve patient outcomes through better testing, today announces the appointment of Damian Thornton to the position of Chief Operating Officer (COO). Damian will be responsible for the organisation’s business operations and strategic planning.

Reporting directly to founder and CEO Peter Keeling, a key focus for Damian will be continuing, and building on, the company’s impressive growth. Diaceutics currently partners with 31 of the world’s top 35 pharmaceutical companies and leverages a database from over 2,500 laboratories in 27 countries. Additional expansion is planned for new markets in Asia and South America.

With more than 25 years of international experience in the pharmaceutical industry, Damian has a significant track record in helping life science companies build and scale. He has led teams and projects across the globe including in China, Japan, the UK, Spain, Singapore, France and Brazil. His specialist knowledge and understanding of the pharmaceutical sector will help Diaceutics ensure more seriously ill patients get properly tested and treated.

Prior to Diaceutics, Damian served as Vice President for Asia at CAI International where he was in charge of strategic planning, project performance and sales forecasting. He was also Global Managing Director at Azbil Telstar and was responsible for growing the life science and research sectors globally, as well as leading the services division’s mergers and acquisitions strategy.

Damian received his bachelor’s degree in Chemical Engineering from Queen’s University Belfast and is a Chartered Member of the Institution of Chemical Engineers.

Peter Keeling, founder and CEO, Diaceutics, said: “It is a hugely exciting time for Diaceutics as we continue to grow our business and expand globally. The more successful we are as a company, the more patient lives we are able to improve and potentially save. 

“We are delighted that Damian, with his extensive experience and understanding of international operations, has joined the Diaceutics team. His in-depth knowledge of the field and hands-on experience in pharma and life science projects will be invaluable in terms of our vision and future expansion.” 

Damian Thornton, COO, Diaceutics, said: “It is an honour to join a company that is transforming an industry and saving thousands of lives by helping patients to receive the right medication at the right time. I am looking forward to being actively involved in the next step of the Diaceutics journey and being a part of its success story.”

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny